Plunkett Research Online: rEVO Biologics Inc

REVO BIOLOGICS INC (Subsidiary) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

REVO Biologics, Inc. develops and commercializes innovative therapeutics for rare diseases. The firm applies transgenic technology to develop recombinant proteins and monoclonal antibodies for human therapeutic uses. REVO uses transgenic animals that express specific recombinant proteins in their .....


REVO BIOLOGICS INC

Ticker: Subsidiary
Exchange:
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 508-620-9700
Fax: 508-370-3797
Address: 175 Crossing Blvd.
Framingham, MA 01702 United States

Types Of Business
Industry Ranks

Industry NAICS code:
Parent Company: LFB SA

ContactsDescription

Yann EchelardCEO/Pres.
Christian BechonDirector
See More
REVO Biologics, Inc. develops and commercializes innovative therapeutics for rare diseases. The firm applies transgenic technology to develop recombinant proteins and monoclonal antibodies for human therapeutic uses. REVO uses transgenic animals that express specific recombinant proteins in their .....See More See More

$USD, In whole numbers 2017201620152014201320122011
Sales
Profits
Brands, Divisions and AffiliatesTop Salaries
Salary
Bonus
Other ThoughtsCorporate Culture